Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer - Earthtimes

Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer - Earthtimes

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service50 times read : Adjust font size: Decrease font Enlarge font
image

DARMSTADT, Germany - (Business Wire) Merck KGaA, Darmstadt, Germany, today announced the initiation of its global Phase III clinical study of the therapeutic cancer vaccine Stimuvax ® (BLP25 liposome vaccine, L-BLP25) in patients with advanced ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright